CON

Concentra Group Holdings Parent Inc

Add to Watchlist

Advanced Chart

19.660

+0.02(0.102%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

20.010

Open

19.740

VWAP

19.69

Vol

698.70K

Mkt Cap

2.52B

Low

19.610

Amount

13.76M

EV/EBITDA(TTM)

11.01

Total Shares

128.17M

4.13B

EV/OCF(TTM)

17.07

P/S(TTM)

0.95

Concentra Group Holdings Parent, Inc. is a provider of occupational health services in the United States. It delivers an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day, on average, from about 620 occupational health centers in 41 states and 160 onsite health clinics at employer worksites in 36 states. Its Occupational Health Centers segment encompasses the services it delivers at its occupational health center facilities across the United States. Its Onsite Health Clinics segment delivers occupational health services and/or employer-sponsored primary care services at an employer’s workplace, including mobile health services and episodic specialty testing services. Its Other Businesses segment comprises several complementary services to its core occupational health services offering and includes Concentra Telemed, Concentra Pharmacy and Concentra Medical Compliance Administration.

4 Analyst Rating

39.88% Upside

Wall Street analysts forecast CON stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CON is 27.50 USD with a low forecast of 25.00 USD and a high forecast of 30.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

4 Buy

0 Hold

0 Sell

Strong Buy

39.88% Upside

Current: 19.660

Low

25.00

Averages

27.50

High

30.00

39.88% Upside

Current: 19.660

Low

25.00

Averages

27.50

High

30.00

JP Morgan

Lisa Gill

Buy

Maintains

$29 → $30

2025-03-19

Reason

JP Morgan

Lisa Gill

Price Target

$29 → $30

2025-03-19

Maintains

Buy

Reason

JPMorgan analyst Lisa Gill raised the firm's price target on Concentra to $30 from $29 and keeps an Overweight rating on the shares. Following Q4 earnings, the firm is updating its estimates, noting that for 2025 it increased its revenue estimate to $2.115B and its adjusted EBITDA estimate to $420M while also increasing its 2026 revenue and adjusted EBITDA estimates.

RBC Capital

Ben Hendrix

Buy

Reiterates

$30

2025-01-23

Reason

RBC Capital

Ben Hendrix

Price Target

$30

2025-01-23

Reiterates

Buy

Reason

B of A Securities

Joanna Gajuk

Strong Buy

Maintains

$24 → $25

2025-01-23

Reason

B of A Securities

Joanna Gajuk

Price Target

$24 → $25

2025-01-23

Maintains

Strong Buy

Reason

BofA raised the firm's price target on Concentra to $25 from $24 and keeps a Buy rating on the shares after the company announced an agreement to acquire Nova Medical Centers for $265M, pre-announced Q4 results, and provided 2025 guide that was roughly in line with consensus excluding the Nova deal contribution. The firm raised its estimates for a better Q4 and the deal and raised its multiple given the increased visibility into estimates.

B of A Securities

Joanna Gajuk

Hold

Strong Buy

Upgrades

$24

2024-12-16

Reason

B of A Securities

Joanna Gajuk

Price Target

$24

2024-12-16

Upgrades

Hold

Strong Buy

Reason

RBC Capital

Ben Hendrix

Buy

Maintains

$33 → $30

2024-11-04

Reason

RBC Capital

Ben Hendrix

Price Target

$33 → $30

2024-11-04

Maintains

Buy

Reason

B of A Securities

Joanna Gajuk

Strong Buy

Hold

Downgrades

$31 → $24

2024-10-07

Reason

B of A Securities

Joanna Gajuk

Price Target

$31 → $24

2024-10-07

Downgrades

Strong Buy

Hold

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Concentra Group Holdings Parent Inc (CON.N) is 14.05, compared to its 5-year average forward P/E of 17.11. For a more detailed relative valuation and DCF analysis to assess Concentra Group Holdings Parent Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

17.11

Current PE

14.05

Overvalued PE

18.80

Undervalued PE

15.43

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

10.76

Current EV/EBITDA

10.69

Overvalued EV/EBITDA

11.65

Undervalued EV/EBITDA

9.88

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

1.35

Current PS

1.15

Overvalued PS

1.45

Undervalued PS

1.24